Search research articles
Contact Us
Filters
Showing results (41-50 of 136) with videos related to
Page
of 14
Sort By:
British Journal of Haematology
|
November 13, 2015
CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status
Tycho Baumann, Julio Delgado, Rodrigo Santacruz, et al.
Blood Purification
|
December 23, 2019
Study of Biocompatibility of Membranes in Online Hemodiafiltration
Raquel Ojeda, Marta Arias-Guillén, Miquel Gómez, et al.
Transplant Immunology
|
May 17, 2006
Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults
Mónica Jiménez, Carmen Martínez, Guadalupe Ercilla, et al.
Blood
|
June 23, 2009
Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM
Roberto Alonso, Mónica López-Guerra, Ramanda Upshaw, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 6, 2003
Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis
Esther Titos, Joan Clària, Anna Planagumà, et al.
Leukemia & Lymphoma
|
November 30, 2021
The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
Leukemia
|
June 15, 2019
Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia
Neus Giménez, Ralph Schulz, Morihiro Higashi, et al.
Blood
|
June 26, 2009
Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience
Pau Abrisqueta, Arturo Pereira, Ciril Rozman, et al.
Leukemia
|
February 5, 2021
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients
Tycho Baumann, Riccardo Moia, Gianluca Gaidano, et al.
Haematologica
|
July 16, 2013
The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells
Laia Rosich, Ifigènia Saborit-Villarroya, Mónica López-Guerra, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 136) with videos related to
Sort By:
Page
of 14
British Journal of Haematology
|
November 13, 2015
CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status
Tycho Baumann, Julio Delgado, Rodrigo Santacruz, et al.
Blood Purification
|
December 23, 2019
Study of Biocompatibility of Membranes in Online Hemodiafiltration
Raquel Ojeda, Marta Arias-Guillén, Miquel Gómez, et al.
Transplant Immunology
|
May 17, 2006
Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults
Mónica Jiménez, Carmen Martínez, Guadalupe Ercilla, et al.
Blood
|
June 23, 2009
Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM
Roberto Alonso, Mónica López-Guerra, Ramanda Upshaw, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 6, 2003
Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis
Esther Titos, Joan Clària, Anna Planagumà, et al.
Leukemia & Lymphoma
|
November 30, 2021
The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
Leukemia
|
June 15, 2019
Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia
Neus Giménez, Ralph Schulz, Morihiro Higashi, et al.
Blood
|
June 26, 2009
Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience
Pau Abrisqueta, Arturo Pereira, Ciril Rozman, et al.
Leukemia
|
February 5, 2021
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients
Tycho Baumann, Riccardo Moia, Gianluca Gaidano, et al.
Haematologica
|
July 16, 2013
The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells
Laia Rosich, Ifigènia Saborit-Villarroya, Mónica López-Guerra, et al.
Page
of 14